CLSH Stock Overview
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States.
Notes are coming soon
CLS Holdings USA, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.068|
|52 Week High||US$0.50|
|52 Week Low||US$0.045|
|1 Month Change||-9.66%|
|3 Month Change||-15.25%|
|1 Year Change||-76.06%|
|3 Year Change||-90.96%|
|5 Year Change||-97.94%|
|Change since IPO||-97.74%|
Recent News & Updates
|CLSH||US Consumer Retailing||US Market|
Return vs Industry: CLSH underperformed the US Consumer Retailing industry which returned 2.1% over the past year.
Return vs Market: CLSH underperformed the US Market which returned -9.2% over the past year.
|CLSH Average Weekly Movement||35.2%|
|Consumer Retailing Industry Average Movement||5.1%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||17.3%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: CLSH is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 35% a week.
Volatility Over Time: CLSH's weekly volatility (35%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators.
CLS Holdings USA, Inc. Fundamentals Summary
|CLSH fundamental statistics|
Is CLSH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CLSH income statement (TTM)|
|Cost of Revenue||US$11.91m|
Last Reported Earnings
Nov 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.16|
|Net Profit Margin||-49.40%|
How did CLSH perform over the long term?See historical performance and comparison